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This is an exciting time for Chemistry G Biology. AS we 
begin our second full year of publication, we can already 
say that the journal is beginning to have the effects we 
had hoped for. The 16 issues published so far have con- 
tained dozens of fascinating papers on a wide range of 
topics relevant to both chemists and biologists; every 
paper has been published expeditiously, and presented in 
a format that is accessible to all our readers. It is equally 
gratifying to see the way in which the Crosstalk and 
Minireview formats have encouraged the exchange of 
information and ideas between groups that, in the past, 
have had little to say to each other.To us, this seems like 
a beginning that could hardly have been bettered. 
Nevertheless, we plan to do even better in the future.We 
have already achieved one improvement in the addition 
of a fourth Associate Editor, Peter Leadlay, to an already 
outstanding editorial team. Peter was trained as an 
organic chemist, but has worked for many years in a very 
biological environment, the Biochemistry Department of 
the University of Cambridge. His work focuses on the 
dissection and manipulation of the multi-enzyme systems 
that synthesize complex compounds such as the poly- 
ketide antibiotics, and his contributions to this area have 
been profound. We are glad to have the benefit of his 
expertise, and we are particularly delighted by his enthu- 
siastic support for the journal. Like many of our contrib- 
utors (and readers), Peter had felt the lack of a journal 
that would report on all the areas in which progress is 
being made towards a chemical understanding of biolog- 
ical processes. We look forward to his help in making 
Chemistry G Biology even more of a natural home for 
papers reporting findings of this kind. 
We are particularly glad that Peter has agreed to join our 
team because he represents a significant increase in our 
representation in Europe; although the papers we have 
published from Europe to date have been excellent, sub- 
missions from the US are still far in the majority.We plan 
to increase the international flavor of the journal consid- 
erably in the coming year. All submissions should con- 
tinue to be sent to the San Francisco office of the 
journal, however. 
The second change we plan is an expansion of content. 
In the 16 issues published so far, it would be fair to say 
that Chemistry 6 Biology has largely focused on the 
central ground of the broad area that constitutes its 
scope, the increasingly significant area in which tech- 
niques and ideas drawn from chemistry overlap with the 
techniques and ideas drawn from biology. We are 
excited by the increase in interest in the journal, seen 
both in the increase in the quality of submissions and in 
the public appreciation of papers that appear in it.There 
can be few journals that attract editorial comment from 
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magazines as diverse as Science, Nature, The Economist, 
Chemical & Engineering News, Business Week and New 
Scientist, among others, all within the first few months 
of publication. This is clearly a reflection of the excel- 
lence of the papers the journal has published so far, as 
well as the unique relevance of their subject matter. But 
some of the areas that we originally included in the 
scope of the journal have so far been under-represented 
in our pages. We expect that the range of subjects 
covered in the journal will expand significantly in the 
coming year, to include more traditionally chemical 
papers.such as those dealing primarily with synthesis, 
molecular design, and natural products chemistry, as well 
as more traditionally biological papers, such as those 
dealing with an understanding of the ways in which 
cells signal, move, divide and metabolize. For those who 
are uncertain of whether a paper is appropriate for the 
journal, we can offer a preliminary editorial opinion on 
the basis of an abstract (which should be sent to the San 
Francisco office). 
The issue of scope brings us to perhaps the most excit- 
ing development of the last year, namely the increasing 
sense we have that the community of researchers who 
work on what might be called ‘chemical biology’ is 
beginning to define itself through the pages of this 
journal. Of course, the concept of chemical biology is 
still a nascent one. Some indication of the increasing 
interest in the areas of research that are the focus of 
Chemistry G Biology comes from changes in the institu- 
tions that harbor both of us. The Harvard Department 
of Chemistry voted last year to change its name to the 
‘Department of Chemistry and Chemical Biology’, and 
the ‘Skaggs Institute of Chemical Biology’ will soon be 
established within the Scripps Research Institute. The 
Harvard vote reflects, in large part, the influence of two 
members of the department, Konrad Bloch and Frank 
Westheimer, both now Emeritus professors, who have 
been pursuing an understanding of the chemical basis of 
biology for at least thirty years. In a way, the only reason 
that this change is surprising is that it took thirty years 
to come.The fact that biological problems are increas- 
ingly well defined from a chemist’s point of view, in part 
thanks to the dramatic progress made by our colleagues 
in structural biology, has certainly contributed to the 
new topicality of chemical approaches to biology. 
One thing that will not change in the coming year is the 
speed and efficiency with which we process submitted 
manuscripts. Many authors have been astonished by the 
rapidity with which our editorial staff handle manu- 
scripts, and it is perhaps worth detailing a few statistics 
here. Considering all primary papers submitted since the 
journal began, we see that the average time from receipt 
to a decision is under 16 days. We have not once taken 
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longer than our self-imposed limit of four weeks to reach 
a decision on a research paper. Equally astonishing is the 
length of time taken once the paper is accepted for it to 
appear in print.Taking the 21st of the month as our issue 
date, the average time from acceptance to publication is 
33 days. Overall, therefore, the average time taken for a 
paper that does not need significant revision to appear in 
print is only seven weeks - many journals, even those 
that pride themselves on rapid publication, cannot 
achieve this rate even for the rare papers that they con- 
sider worthy of accelerated review. This speedy treatment 
does not mean that we compromise on quality, however. 
Speaking as authors ourselves, we have been impressed by 
the thoroughness of the refereeing process, and the care 
taken in preparing manuscripts for publication. 
Publication, these days, does not only mean print publi- 
cation. Electronic publishing seems certain to be a true 
revolution in the way we access information, and readers 
(and authors) of the journal will be glad to know that 
Chemistr)) G Biolqgy is taking full advantage of the new 
opportunities it provides. The full text, complete with 
figures, of all CIzemistry G Biology issues published last 
year is now available to subscribers in searchable format 
via the BioMedNet site on the World Wide Web. New 
issues will also be available in electronic format before 
the printed version reaches most subscribers. More infor- 
mation on BioMedNet can be found elsewhere in this 
issue or at http://BioMedNet.com. 
We are grateful for the support of all those who have 
given the journal such a good start, especially our 
Associate Editors, the editorial and technical staff in 
San Francisco and London, our excellent and respon- 
sive referees, and of course our authors and subscribers. 
We now look forward to your continued support, and 
to your comments and suggestions, as we strive for 
further improvements. 
